Cellular Biomedicine Group Inc (CBMG)

[Exodus]

the next 4 quarters are financed
--> good price!

On March 25, 2015, Cellular Biomedicine Group, Inc. (the “Company”) conducted an initial closing of a financing transaction (the “Financing”) pursuant to which it sold an aggregate of 394,740 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), to selected investors (the “Investors”) at $38.00 per share, for total gross proceeds of approximately $15,000,000.